Stock Research for ATOS

ATOS

Featured Broker: Ally Invest

Get the due diligence for another stock.

 

ATOS Stock Chart & Research Data

The ATOS chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the ATOS chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


 


ATOS Due diligence Resources & Stock Charts

The ATOS stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View ATOS Detailed Price Forecast - CNN Money CNN View ATOS Detailed Summary - Google Finance
Yahoo View ATOS Detailed Summary - Yahoo! Finance Zacks View ATOS Stock Research & Analysis - Zacks.com

Stock Analysis

TradeIdeas View ATOS Trends & Analysis - Trade-Ideas Barrons View ATOS Major Holders - Barrons
NASDAQ View ATOS Call Transcripts - NASDAQ Seeking View ATOS Breaking News & Analysis - Seeking Alpha
Spotlight View ATOS Annual Report - CompanySpotlight.com OTC Report View ATOS OTC Short Report - OTCShortReport.com
TradeKing View ATOS Fundamentals - TradeKing Charts View ATOS SEC Filings - Bar Chart
WSJ View Historical Prices for ATOS - The WSJ Morningstar View Performance/Total Return for ATOS - Morningstar
MarketWatch View the Analyst Estimates for ATOS - MarketWatch CNBC View the Earnings History for ATOS - CNBC
StockMarketWatch View the ATOS Earnings - StockMarketWatch MacroAxis View ATOS Buy or Sell Recommendations - MacroAxis
Bullish View the ATOS Bullish Patterns - American Bulls Short Pains View ATOS Short Pain Metrics - ShortPainBot.com

Social Media Mentions

StockTwits View ATOS Stock Mentions - StockTwits PennyStocks View ATOS Stock Mentions - PennyStockTweets
Twitter View ATOS Stock Mentions - Twitter Invest Hub View ATOS Investment Forum News - Investor Hub
Yahoo View ATOS Stock Mentions - Yahoo! Message Board Seeking Alpha View ATOS Stock Mentions - Seeking Alpha


Financial & Transaction Holdings

SECform4 View Insider Transactions for ATOS - SECform4.com Insider Cow View Insider Transactions for ATOS - Insider Cow
CNBC View ATOS Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for ATOS - OTC Markets
Yahoo View Insider Transactions for ATOS - Yahoo! Finance NASDAQ View Institutional Holdings for ATOS - NASDAQ


Stock Charts

FinViz View ATOS Stock Insight & Charts - FinViz.com StockCharts View ATOS Investment Charts - StockCharts.com
BarChart View ATOS Stock Overview & Charts - BarChart Trading View View ATOS User Generated Charts - Trading View




Latest Financial News for ATOS


Edison issues outlook on Atossa Genetics (ATOS)
Posted on Friday December 07, 2018

LONDON, Dec. 07, 2018 -- Atossa Genetics’s (ATOS) endoxifen programs are advancing in their respective breast health programs. The firm recently reported positive safety data.


Atossa Genetics Announces FDA Approval  of Endoxifen for “Expanded Access” as Preoperative Systemic Endocrine Therapy for a U.S. Breast Cancer Patient
Posted on Monday December 03, 2018

Steven C. Quay, Ph.D., MD, President and CEO commented, “A physician recently contacted Atossa and requested our proprietary oral Endoxifen for a pre-menopausal, estrogen-receptor positive (ER+) breast cancer patient awaiting surgery. In this setting, the recommended preoperative endocrine systemic therapy is typically an aromatase inhibitor and a drug for ovarian suppression.


''A Spate of Factors'' Vista Partners November 2018 Macro Economic and Investment Newsletter
Posted on Wednesday November 21, 2018

SAN FRANCISCO, CA / ACCESSWIRE / November 21, 2018 / Vista Partners ("Vista") has published November's FREE Macroeconomic & Investment Monthly Newsletter, "A Spate of Factors." Vista's ...


Atossa Genetics Announces Third Quarter 2018 Financial Results And Provides Company Update
Posted on Tuesday November 13, 2018

SEATTLE, Nov. 13, 2018 -- Atossa Genetics Inc. (NASDAQ: ATOS), a clinical-stage biopharmaceutical company developing novel therapeutics and delivery methods to treat breast.


Stock Market & Investing Books

Enter a stock symbol to view the stock details.